234 related articles for article (PubMed ID: 37550950)
1. Amplifying "eat me signal" by immunogenic cell death for potentiating cancer immunotherapy.
Xi Y; Chen L; Tang J; Yu B; Shen W; Niu X
Immunol Rev; 2024 Jan; 321(1):94-114. PubMed ID: 37550950
[TBL] [Abstract][Full Text] [Related]
2. Immunogenic Cell Death Activates the Tumor Immune Microenvironment to Boost the Immunotherapy Efficiency.
Li Z; Lai X; Fu S; Ren L; Cai H; Zhang H; Gu Z; Ma X; Luo K
Adv Sci (Weinh); 2022 Aug; 9(22):e2201734. PubMed ID: 35652198
[TBL] [Abstract][Full Text] [Related]
3. Emerging photodynamic nanotherapeutics for inducing immunogenic cell death and potentiating cancer immunotherapy.
Zhang S; Wang J; Kong Z; Sun X; He Z; Sun B; Luo C; Sun J
Biomaterials; 2022 Mar; 282():121433. PubMed ID: 35202933
[TBL] [Abstract][Full Text] [Related]
4. Stimuli-responsive nanodelivery systems for amplifying immunogenic cell death in cancer immunotherapy.
Xu W; Liu W; Yang J; Lu J; Zhang H; Ye D
Immunol Rev; 2024 Jan; 321(1):181-198. PubMed ID: 37403660
[TBL] [Abstract][Full Text] [Related]
5. Engineering nanomedicines through boosting immunogenic cell death for improved cancer immunotherapy.
Gao J; Wang WQ; Pei Q; Lord MS; Yu HJ
Acta Pharmacol Sin; 2020 Jul; 41(7):986-994. PubMed ID: 32317755
[TBL] [Abstract][Full Text] [Related]
6. Chemotherapeutic drug-induced immunogenic cell death for nanomedicine-based cancer chemo-immunotherapy.
Jiang M; Zeng J; Zhao L; Zhang M; Ma J; Guan X; Zhang W
Nanoscale; 2021 Oct; 13(41):17218-17235. PubMed ID: 34643196
[TBL] [Abstract][Full Text] [Related]
7. Nanomedicines for an Enhanced Immunogenic Cell Death-Based
Zhao C; Wang C; Shan W; Wang Z; Chen X; Deng H
Acc Chem Res; 2024 Mar; 57(6):905-918. PubMed ID: 38417027
[TBL] [Abstract][Full Text] [Related]
8. Bioactive Peptide Nanodrugs Based on Supramolecular Assembly for Boosting Immunogenic Cell Death-Induced Cancer Immunotherapy.
Liu Y; Chang R; Xing R; Yan X
Small Methods; 2023 May; 7(5):e2201708. PubMed ID: 36720041
[TBL] [Abstract][Full Text] [Related]
9. Recent progress in stimuli-responsive nanosystems for inducing immunogenic cell death.
Banstola A; Poudel K; Kim JO; Jeong JH; Yook S
J Control Release; 2021 Sep; 337():505-520. PubMed ID: 34314800
[TBL] [Abstract][Full Text] [Related]
10. Reinforcing the immunogenic cell death to enhance cancer immunotherapy efficacy.
Yu S; Xiao H; Ma L; Zhang J; Zhang J
Biochim Biophys Acta Rev Cancer; 2023 Sep; 1878(5):188946. PubMed ID: 37385565
[TBL] [Abstract][Full Text] [Related]
11. Rediscovery of nanoparticle-based therapeutics: boosting immunogenic cell death for potential application in cancer immunotherapy.
Yang S; Sun IC; Hwang HS; Shim MK; Yoon HY; Kim K
J Mater Chem B; 2021 May; 9(19):3983-4001. PubMed ID: 33909000
[TBL] [Abstract][Full Text] [Related]
12. [Comparison of three commercial photosensitizers for efficiency of inducing immunogenic cell death in anti-tumor immunotherapy].
Lin X; Mao D; Bai R
Nan Fang Yi Ke Da Xue Xue Bao; 2022 Dec; 42(12):1791-1798. PubMed ID: 36651246
[TBL] [Abstract][Full Text] [Related]
13. Light triggered release of a triple action porphyrin-cisplatin conjugate evokes stronger immunogenic cell death for chemotherapy, photodynamic therapy and cancer immunotherapy.
Song H; Cai Z; Li J; Xiao H; Qi R; Zheng M
J Nanobiotechnology; 2022 Jul; 20(1):329. PubMed ID: 35842642
[TBL] [Abstract][Full Text] [Related]
14. Multifunctional Nano-Biomaterials for Cancer Therapy via Inducing Enhanced Immunogenic Cell Death.
Chen Q; Li C; Wang Q
Small Methods; 2023 May; 7(5):e2201457. PubMed ID: 36703555
[TBL] [Abstract][Full Text] [Related]
15. Microbes mediated immunogenic cell death in cancer immunotherapy.
Huang J; Duan F; Xie C; Xu J; Zhang Y; Wang Y; Tang YP; Leung EL
Immunol Rev; 2024 Jan; 321(1):128-142. PubMed ID: 37553793
[TBL] [Abstract][Full Text] [Related]
16. Targeting immunogenic cancer cell death by photodynamic therapy: past, present and future.
Alzeibak R; Mishchenko TA; Shilyagina NY; Balalaeva IV; Vedunova MV; Krysko DV
J Immunother Cancer; 2021 Jan; 9(1):. PubMed ID: 33431631
[TBL] [Abstract][Full Text] [Related]
17. Nano Delivery of Chemotherapeutic ICD Inducers for Tumor Immunotherapy.
Guo J; Zou Y; Huang L
Small Methods; 2023 May; 7(5):e2201307. PubMed ID: 36604976
[TBL] [Abstract][Full Text] [Related]
18. Nanomaterials-Based Photodynamic Therapy with Combined Treatment Improves Antitumor Efficacy Through Boosting Immunogenic Cell Death.
Jin F; Liu D; Xu X; Ji J; Du Y
Int J Nanomedicine; 2021; 16():4693-4712. PubMed ID: 34267518
[TBL] [Abstract][Full Text] [Related]
19. Targeting immunogenic cell death in cancer.
Ahmed A; Tait SWG
Mol Oncol; 2020 Dec; 14(12):2994-3006. PubMed ID: 33179413
[TBL] [Abstract][Full Text] [Related]
20. Realizing the Clinical Potential of Immunogenic Cell Death in Cancer Chemotherapy and Radiotherapy.
Rapoport BL; Anderson R
Int J Mol Sci; 2019 Feb; 20(4):. PubMed ID: 30813267
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]